ADDvise Group B (ADDV-B) - Net Assets

Latest as of September 2025: Skr1.11 Billion SEK ≈ $119.32 Million USD

Based on the latest financial reports, ADDvise Group B (ADDV-B) has net assets worth Skr1.11 Billion SEK (≈ $119.32 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr2.92 Billion ≈ $313.77 Million USD) and total liabilities (Skr1.81 Billion ≈ $194.44 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore ADDV-B cash flow metrics to assess how effectively this company generates cash.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr1.11 Billion
% of Total Assets	38.03%
Annual Growth Rate	38.48%
5-Year Change	817.09%
10-Year Change	19537.82%
Growth Volatility	235.73

ADDvise Group B - Net Assets Trend (2007–2024)

This chart illustrates how ADDvise Group B's net assets have evolved over time, based on quarterly financial data. Also explore ADDV-B total asset value for the complete picture of this company's asset base.

Annual Net Assets for ADDvise Group B (2007–2024)

The table below shows the annual net assets of ADDvise Group B from 2007 to 2024. For live valuation and market cap data, see ADDV-B stock market capitalisation.

Year	Net Assets	Change
2024-12-31	Skr835.00 Million ≈ $89.86 Million	+36.17%
2023-12-31	Skr613.20 Million ≈ $65.99 Million	+24.41%
2022-12-31	Skr492.87 Million ≈ $53.04 Million	+99.32%
2021-12-31	Skr247.28 Million ≈ $26.61 Million	+171.58%
2020-12-31	Skr91.05 Million ≈ $9.80 Million	+8.21%
2019-12-31	Skr84.14 Million ≈ $9.06 Million	+63.67%
2018-12-31	Skr51.41 Million ≈ $5.53 Million	+4.90%
2017-12-31	Skr49.01 Million ≈ $5.27 Million	+6.44%
2016-12-31	Skr46.04 Million ≈ $4.96 Million	+982.88%
2015-12-31	Skr4.25 Million ≈ $457.58K	-71.42%
2014-12-31	Skr14.88 Million ≈ $1.60 Million	+34.36%
2013-12-31	Skr11.07 Million ≈ $1.19 Million	+14.79%
2012-12-31	Skr9.65 Million ≈ $1.04 Million	+4.37%
2011-12-31	Skr9.24 Million ≈ $994.69K	+114.70%
2010-12-31	Skr4.30 Million ≈ $463.29K	+85.24%
2008-12-31	Skr2.32 Million ≈ $250.10K	-29.49%
2007-12-31	Skr3.30 Million ≈ $354.70K	--

Equity Component Analysis

This analysis shows how different components contribute to ADDvise Group B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 13934.2% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	Skr271.00 Million	32.46%
Common Stock	Skr19.90 Million	2.38%
Other Comprehensive Income	Skr37.90 Million	4.54%
Other Components	Skr506.20 Million	60.62%
Total Equity	Skr835.00 Million	100.00%

ADDvise Group B Competitors by Market Cap

The table below lists competitors of ADDvise Group B ranked by their market capitalization.

Company	Market Cap
Fury Gold Mines Ltd TO:FURY	$108.65 Million
Supercomnet Technologies Bhd KLSE:0001	$108.67 Million
Daechang Forgi KO:015230	$108.67 Million
Lotus Resources Ltd AU:LOT	$108.69 Million
ITEK Inc KQ:119830	$108.56 Million
Iceland Seafood International hf. IC:ICESEA	$108.43 Million
RF Acquisition Corp II Unit NASDAQ:RFAIU	$108.40 Million
Volati AB ST:VOLO-PREF	$108.39 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in ADDvise Group B's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 613,200,000 to 835,000,000, a change of 221,800,000 (36.2%).
Net income of 90,000,000 contributed positively to equity growth.
Share repurchases of 100,100,000 reduced equity.
New share issuances of 100,100,000 increased equity.
Other comprehensive income increased equity by 36,000,000.
Other factors increased equity by 95,800,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Skr90.00 Million	+10.78%
Share Repurchases	Skr100.10 Million	-11.99%
Share Issuances	Skr100.10 Million	+11.99%
Other Comprehensive Income	Skr36.00 Million	+4.31%
Other Changes	Skr95.80 Million	+11.47%
Total Change	Skr-	36.17%

Book Value vs Market Value Analysis

This analysis compares ADDvise Group B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.41x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 0.89x to 0.41x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2007-12-31	Skr1.93	Skr1.73	x
2008-12-31	Skr1.36	Skr1.73	x
2010-12-31	Skr1.18	Skr1.73	x
2011-12-31	Skr1.64	Skr1.73	x
2012-12-31	Skr0.90	Skr1.73	x
2013-12-31	Skr0.71	Skr1.73	x
2014-12-31	Skr1.27	Skr1.73	x
2015-12-31	Skr0.18	Skr1.73	x
2016-12-31	Skr1.04	Skr1.73	x
2017-12-31	Skr0.76	Skr1.73	x
2018-12-31	Skr1.19	Skr1.73	x
2019-12-31	Skr0.89	Skr1.73	x
2020-12-31	Skr0.80	Skr1.73	x
2021-12-31	Skr1.73	Skr1.73	x
2022-12-31	Skr2.78	Skr1.73	x
2023-12-31	Skr3.30	Skr1.73	x
2024-12-31	Skr4.24	Skr1.73	x

Capital Efficiency Dashboard

This dashboard shows how efficiently ADDvise Group B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 10.78%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 5.39%
• Asset Turnover: 0.48x
• Equity Multiplier: 4.13x
Recent ROE (10.78%) is above the historical average (-25.92%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2007	33.40%	3.30%	2.83x	3.57x	Skr771.40K
2008	-41.78%	-2.83%	2.66x	5.56x	Skr-1.20 Million
2010	-110.82%	-21.41%	1.04x	5.00x	Skr-5.20 Million
2011	-2.98%	-0.54%	2.16x	2.53x	Skr-1.20 Million
2012	-37.27%	-3.58%	1.48x	7.03x	Skr-4.56 Million
2013	-41.23%	-3.80%	1.37x	7.89x	Skr-5.67 Million
2014	-32.00%	-3.45%	0.83x	11.19x	Skr-6.25 Million
2015	-261.01%	-7.57%	1.14x	30.33x	Skr-11.52 Million
2016	0.81%	0.19%	0.87x	4.89x	Skr-4.22 Million
2017	-11.90%	-2.42%	0.86x	5.69x	Skr-10.70 Million
2018	-2.09%	-0.40%	0.92x	5.68x	Skr-6.19 Million
2019	4.83%	1.16%	0.97x	4.29x	Skr-4.34 Million
2020	16.09%	4.08%	1.04x	3.80x	Skr5.54 Million
2021	1.13%	0.60%	0.44x	4.32x	Skr-21.92 Million
2022	16.45%	8.52%	0.48x	3.99x	Skr31.81 Million
2023	16.88%	7.54%	0.42x	5.36x	Skr42.18 Million
2024	10.78%	5.39%	0.48x	4.13x	Skr6.50 Million

Industry Comparison

This section compares ADDvise Group B's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

Industry: Medical Instruments & Supplies
Average net assets among peers: $396,807,000
Average return on equity (ROE) among peers: -42.78%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
ADDvise Group B (ADDV-B)	Skr1.11 Billion	33.40%	1.63x	$108.58 Million
ADDvise Group AB A (ADDV-A)	$9.65 Million	-37.27%	6.03x	$4.23 Million
AddLife AB (publ) (ALIF-B)	$1.48 Billion	9.52%	1.22x	$1.90 Billion
Biotage AB (BIOT)	$609.50 Million	-40.10%	0.36x	$1.23 Billion
Bio-Works Technologies AB (BIOWKS)	$99.32 Million	-23.82%	0.06x	$45.74 Million
Bonesupport Holding AB (BONEX)	$727.46 Million	18.39%	0.21x	$1.67 Billion
Dynavox Group (DYVOX)	$603.00 Million	27.48%	3.10x	$908.16 Million
iZafe Group AB Series B (IZAFE-B)	$9.73 Million	-210.82%	1.49x	$17.39 Million
Ortivus AB ser. A (ORTI-A)	$5.22 Million	-135.56%	8.05x	$415.12K
Ortivus AB ser. B (ORTI-B)	$31.19 Million	7.12%	0.71x	$16.84 Million

About ADDvise Group B

ST:ADDV-B Sweden Medical Instruments & Supplies

Market Cap

$108.58 Million

Skr1.01 Billion SEK

Market Cap Rank

#18999 Global

#335 in Sweden

Share Price

Skr1.73

Change (1 day)

+0.00%

52-Week Range

Skr1.01 - Skr1.89

All Time High

Skr16.82